ArticleFrontiers in oncology2025
Case Report: A rare case of ALK-KIF5B gene fusion benefited from treatment with lorlatinib.
Yuxi Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleFrontiers in oncology2025
Yuxi Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.